While it is commonly understood that a difficult childhood can lead to mental health issues, research has now exposed deeper, more troubling impacts of early life adversity: that these experiences...
In line with our commitment to advancing brain research excellence at McGill, HBHL is happy to introduce five exceptional recruits who have recently joined McGill across three different faculties....
Type 1 diabetes, rheumatoid arthritis, and cancer are just some of the disorders associated with specific genes not “turning on” and “turning off” as they should. By using new CRISPR/Cas9 genome...
Many of the drugs and medicines that we rely on today are natural products taken from microbes like bacteria and fungi. Within these microbes, the drugs are made by tiny natural machines – mega...
Depression is a common psychiatric disorder and one of the leading causes of disability worldwide. Antidepressants are the first-line treatment for moderate to severe major depressive episodes....
An international team, that includes researchers from McGill, has completed the most comprehensive study of whole cancer genomes to date, significantly improving our fundamental understanding of...
The Consortium for Industrial Research and Innovation in Medical Technologies, MEDTEQ, and the Healthy Brains for Healthy Lives (HBHL) initiative of McGill University are pleased to announce a...
RSS